IndiaTickerVanta Bioscience Ltd - 540729 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 30.05.2026BSE · exchange filing · pdf
Source filing Company dossier
Vanta Bioscience
BSE:VANTABIO · ISIN INE695X01011
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Vanta Bioscience
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Vanta Bioscience Ltd - 540729 - Audited Standalone And Consolidated Financial Results For The Half Year And Financial Year Ended March 31, 2026BSE · financial results · pdf
Source filing Vanta Bioscience Ltd - 540729 - Board Meeting Intimation for Approval Of Standalone And Consolidated Audited Financial Results For The Half Year And Financial Year Ended March 31, 2026 - Board Meeting To Be Held On May 30, 2026BSE · financial results · pdf
Source filing Vanta Bioscience Ltd - 540729 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Vanta Bioscience Ltd - 540729 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Vanta Bioscience Ltd - 540729 - Clarification On Movement In PriceBSE · exchange filing · pdf
Source filing Vanta Bioscience Ltd - 540729 - Board Meeting Outcome for Outcome Of The Board Meeting - Appointment Of Company Secretary And Compliance OfficerBSE · exchange filing · pdf
Source filing Vanta Bioscience Ltd - 540729 - Financial Results For The Half Year Ended September 30, 2025BSE · financial results · pdf
Source filing Vanta Bioscience Ltd - 540729 - Board Meeting Outcome for Outcome Of The Board Meeting Held On November 14, 2025BSE · exchange filing · pdf
Source filing Vanta Bioscience Ltd - 540729 - Board Meeting Intimation for Board Meeting To Be Held On 14.11.2025BSE · financial results · pdf
Source filing Vanta Bioscience Ltd - 540729 - Reg. 34 (1) Annual Report.BSE · annual report · pdf
Archived filing Vanta Bioscience Ltd - 540729 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerBSE · exchange filing · pdf
Source filing Vanta Bioscience Ltd - 540729 - Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportBSE · exchange filing · pdf
Source filing Vanta Bioscience Ltd - 540729 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Vanta Bioscience Ltd - 540729 - Shareholder Meeting / Postal Ballot-Outcome of AGMBSE · exchange filing · pdf
Source filing Vanta Bioscience Ltd - 540729 - Board Meeting Outcome for Outcome Of Board Meeting Held On 06.09.2025BSE · exchange filing · pdf
Source filing Vanta Bioscience Ltd - 540729 - Financials For The Half Year And Year Ended 31.03.2025BSE · financial results · pdf
Source filing Vanta Bioscience Ltd - 540729 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 01.08.2025BSE · exchange filing · pdf
Source filing Vanta Bioscience Ltd - 540729 - Board Meeting Intimation for Postponement Of Board Meeting To August 01, 2025BSE · financial results · pdf
Source filing Vanta Bioscience Ltd - 540729 - Board Meeting Intimation for Postponement Of Board Meeting To July 29, 2025BSE · financial results · pdf
Source filing Vanta Bioscience Ltd - 540729 - Board Meeting Intimation for Postponement Of Board Meeting Scheduled On July 19, 2025 And Will Now Be Held On Thursday, July 24, 2025BSE · financial results · pdf
Source filing Vanta Bioscience Ltd - 540729 - Board Meeting Intimation for Board Meeting To Be Held On July 19, 2025BSE · financial results · pdf
Source filing Vanta Bioscience Ltd - 540729 - Rejection Of Promoter Reclassification ApplicationBSE · exchange filing · pdf
Source filing Vanta Bioscience Ltd - 540729 - Results-Delay in Financial ResultsBSE · financial results · pdf
Source filing Vanta Bioscience Ltd - 540729 - Cancellation of Board MeetingBSE · exchange filing · pdf
Source filing Vanta Bioscience Ltd - 540729 - Board Meeting Intimation for Board Meeting On 30/05/2025BSE · financial results · pdf
Source filing Vanta Bioscience Ltd - 540729 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Vanta Bioscience Ltd - 540729 - Board Meeting Outcome for Outcome Of Board Meeting Held On 06.05.2025BSE · exchange filing · pdf
Source filing Vanta Bioscience Ltd - 540729 - Intimation Regarding Receipt Of GLP Re-Certification For The Facility Of The Company In Gummidipundi, Tamil NaduBSE · exchange filing · pdf
Source filing Vanta Bioscience Ltd - 540729 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Vanta Bioscience Ltd - 540729 - Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportBSE · exchange filing · pdf
Source filing Vanta Bioscience Ltd - 540729 - Shareholder Meeting / Postal Ballot-Outcome of EGMBSE · exchange filing · pdf
Source filing Vanta Bioscience Ltd - 540729 - Notice Of EGM To Be Held On 04.01.2025BSE · exchange filing · pdf
Source filing Vanta Bioscience Ltd - 540729 - EGM On 04.01.2025BSE · exchange filing · pdf
Source filing Vanta Bioscience Ltd - 540729 - Board Meeting Outcome for Outcome Of Board Meeting Held On 06.12.2024BSE · exchange filing · pdf
Source filing Vanta Bioscience Ltd - 540729 - Board Meeting Intimation for Conversion Of Unsecured Loans Into Equity SharesBSE · exchange filing · pdf
Source filing Vanta Bioscience Ltd - 540729 - Board Meeting Outcome for Outcome Of Board Meeting Held On 14.11.2024BSE · exchange filing · pdf
Source filing Vanta Bioscience Ltd - 540729 - Unaudited Results For 30.09.2024BSE · financial results · pdf
Source filing Vanta Bioscience Ltd - 540729 - Board Meeting Intimation for Approval Of Un-Audited Financial Statements Of 30.09.2024 And Conversion Of Unsecured Loans Into Equity SharesBSE · exchange filing · pdf
Source filing Vanta Bioscience Ltd - 540729 - Reply To Clarification On Price Movement Sought By BSEBSE · exchange filing · pdf
Source filing